Researchers are poised to make huge advances in medicine, particularly in how we treat cancer and arthritis. See how big data and IT are contributing.
The Precision Medicine Initiative Cohort Program
What if we could study the ongoing health records of more than 1 million people to learn which individuals respond to certain types of drugs, are at risk for a certain disease, maintain health and fitness, age, and die? That's the goal of the $130 million Precision Medicine Initiative Cohort Program (part of a precision health initiative, with an overall $215 million annual budget) being done by the National Institute of Health. The goal is to enroll over 1 million Americans in the cohort in the next three to four years. The data (anonymous, of course) from all 1 million individuals will be furnished to any interested researcher who wants to study one of the largest cohorts ever made available.
All members of the cohort will have their genomes sequenced, and their health history, lifestyle habits, and environmental exposures tracked. By doing so, the study will yield a treasure trove of big data. It will allow people to track the effectiveness of medicine based on genetic markers and identify certain biomarkers that signify that people might be at risk for a given disease.
Global Big Data Conference